Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Meyer, J. H. Articles by Kennedy, S. H. Search for Related Content PubMed Citation Articles by Meyer, J. H. Articles by Kennedy, S. H. Neurotransmitters Depression Antidepressants PET

The Effect of Paroxetine on 5-HT_2A Receptors in Depression: An [¹⁸F]Setoperone PET Imaging Study

OBJECTIVE: In the cortex of animals, serotonin (5-HT) levels increase after several weeks of treatment with selective serotonin reuptake inhibitors (SSRIs). Studies using an intrasubject design to examine the effects of SSRI treatment on 5-HT_2A receptors in the cortex of drug-free depressed patients are needed. In theory, agonist stimulation of 5-HT_2A receptors could be relevant to SSRI treatment by promoting neuronal growth and survival as well as direct elevation of mood. The objective of this study was to evaluate the effect of 6 weeks of paroxetine treatment on 5-HT_2A receptors in depressed patients. METHOD: After a medication-free period of at least 3 months, 19 depressed patients were treated for 6 weeks with paroxetine, 20 mg/day. The authors used [¹⁸F]setoperone and positron emission tomography to assess 5-HT_2A receptor binding potential in the patients before and after treatment and in 19 age-matched healthy subjects. RESULTS: 5-HT_2A binding potential declined with age in all cortical regions in the depressed and healthy subjects. There was a significant interaction between age and treatment effect on 5-HT_2A binding potential in all cortical regions. Subjects aged 20 to 30 years had a 10% decrease in 5-HT_2A binding potential after treatment, whereas subjects aged 30 to 40 had no change. No regional differences in 5-HT_2A binding potential between depressed and healthy subjects were found. CONCLUSIONS: 5-HT_2A receptors down-regulate in young depressed subjects after treatment with paroxetine, but this down-regulation attenuates with age. This suggests that over 6 weeks paroxetine treatment increases 5-HT agonism on 5-HT_2A receptors in the cortex of young patients with depression.

This article has been cited by other articles:

				S. Kruger, M. Alda, L. T. Young, K. Goldapple, S. Parikh, and H. S. Mayberg Risk and Resilience Markers in Bipolar Disorder: Brain Responses to Emotional Challenge in Bipolar Patients and Their Healthy Siblings Am J Psychiatry, February 1, 2006; 163(2): 257 - 264. [Abstract] [Full Text] [PDF]

				J. H. Meyer, S. Houle, S. Sagrati, A. Carella, D. F. Hussey, N. Ginovart, V. Goulding, J. Kennedy, and A. A. Wilson Brain Serotonin Transporter Binding Potential Measured With Carbon 11-Labeled DASB Positron Emission Tomography: Effects of Major Depressive Episodes and Severity of Dysfunctional Attitudes Arch Gen Psychiatry, December 1, 2004; 61(12): 1271 - 1279. [Abstract] [Full Text] [PDF]

				J. H. Meyer, A. A. Wilson, S. Sagrati, D. Hussey, A. Carella, W. Z. Potter, N. Ginovart, E. P. Spencer, A. Cheok, and S. Houle Serotonin Transporter Occupancy of Five Selective Serotonin Reuptake Inhibitors at Different Doses: An [11C]DASB Positron Emission Tomography Study Am J Psychiatry, May 1, 2004; 161(5): 826 - 835. [Abstract] [Full Text] [PDF]

				J. H. Meyer, S. McMain, S. H. Kennedy, L. Korman, G. M. Brown, J. N. DaSilva, A. A. Wilson, T. Blak, R. Eynan-Harvey, V. S. Goulding, et al. Dysfunctional Attitudes and 5-HT2 Receptors During Depression and Self-Harm Am J Psychiatry, January 1, 2003; 160(1): 90 - 99. [Abstract] [Full Text] [PDF]

				M. J. Millan, A. Gobert, F. Lejeune, A. Newman-Tancredi, J.-M. Rivet, A. Auclair, and J.-L. Peglion S33005, a Novel Ligand at Both Serotonin and Norepinephrine Transporters: I. Receptor Binding, Electrophysiological, and Neurochemical Profile in Comparison with Venlafaxine, Reboxetine, Citalopram, and Clomipramine J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 565 - 580. [Abstract] [Full Text] [PDF]

				S. H. Kennedy, K. R. Evans, S. Kruger, H. S. Mayberg, J. H. Meyer, S. McCann, A. I. Arifuzzman, S. Houle, and F. J. Vaccarino Changes in Regional Brain Glucose Metabolism Measured With Positron Emission Tomography After Paroxetine Treatment of Major Depression Am J Psychiatry, June 1, 2001; 158(6): 899 - 905. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2001 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us